Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha Thomas

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Gastroenterology|January 23, 2015
Diet and irritable bowel syndromeAnusha Thomas, Eamonn M M Quigley
Current Opinion in Gastroenterology|July 26, 2022
Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)Ahmed Sayed Ahmed, Michael Abreo, Anusha Thomas, et al.
Cureus|May 13, 2024
A Comprehensive Narrative Review of Neuropathic Pain: From Pathophysiology to Surgical TreatmentBruno Lima Pessôa, Wilhelmina N Hauwanga, Anusha Thomas, et al.
Cureus|February 15, 2024
Temporal Trends of Age-Adjusted Mortality Rates for Rheumatic Heart Disease in Brazil From 2000 to 2021Billy McBenedict, Zaeemah Mansoor, Abhishek Chaudhary, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|July 20, 2022
Voice Onset Time in Early- and Late-Stage Amyotrophic Lateral SclerosisAnusha Thomas, Kristin J Teplansky, Alan Wisler, et al.
Annals of Gastroenterology|January 13, 2025
Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancerAntonio Pizuorno Machado, Saltenat Moghaddam Adames, Malek Shatila, et al.
Immunotherapy|March 8, 2025
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and managementCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Journal of Cancer Research and Clinical Oncology|February 8, 2023
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseasesAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2022
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitisAlice Saji, Maneera Chopra, Jake Jacob, et al.
Cureus|September 27, 2024
Approaches in Adult Glioblastoma Treatment: A Systematic Review of Emerging TherapiesBilly McBenedict, Wilhelmina N Hauwanga, Anna Pogodina, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Gastroenterology|January 23, 2015
Diet and irritable bowel syndromeAnusha Thomas, Eamonn M M Quigley
Current Opinion in Gastroenterology|July 26, 2022
Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)Ahmed Sayed Ahmed, Michael Abreo, Anusha Thomas, et al.
Cureus|May 13, 2024
A Comprehensive Narrative Review of Neuropathic Pain: From Pathophysiology to Surgical TreatmentBruno Lima Pessôa, Wilhelmina N Hauwanga, Anusha Thomas, et al.
Cureus|February 15, 2024
Temporal Trends of Age-Adjusted Mortality Rates for Rheumatic Heart Disease in Brazil From 2000 to 2021Billy McBenedict, Zaeemah Mansoor, Abhishek Chaudhary, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|July 20, 2022
Voice Onset Time in Early- and Late-Stage Amyotrophic Lateral SclerosisAnusha Thomas, Kristin J Teplansky, Alan Wisler, et al.
Annals of Gastroenterology|January 13, 2025
Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancerAntonio Pizuorno Machado, Saltenat Moghaddam Adames, Malek Shatila, et al.
Immunotherapy|March 8, 2025
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and managementCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Journal of Cancer Research and Clinical Oncology|February 8, 2023
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseasesAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2022
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitisAlice Saji, Maneera Chopra, Jake Jacob, et al.
Cureus|September 27, 2024
Approaches in Adult Glioblastoma Treatment: A Systematic Review of Emerging TherapiesBilly McBenedict, Wilhelmina N Hauwanga, Anna Pogodina, et al.
Pageof 3